Sumanta Pal, Professor and Vice Chair of Academic Affairs at City of Hope, shared a post on LinkedIn by City of Hope, adding:
“Not a single Thanksgiving has gone by over the past decade when I haven’t been grateful for having my boss/ally/friend Tanya Dorff at City of Hope. Beyond the incredible strides she has made in immunotherapy for prostate cancer, she has led our growing group with integrity, empathy, and inspiration.
It was an honor to sit down with her this week on our podcast to hear what she feels the future holds for cancer research. Listen to the link below.”
Quoting City of Hope’s post:
“In the latest episode of On the Edge of Breakthrough: Voices of Cancer Research, Sumanta Pal welcomes Dr. Tanya Dorff, professor in the Department of Medical Oncology and Therapeutics Research and section chief of the Genitourinary Disease Program at City of Hope.
They dive into Dr. Dorff’s pioneering work in immunotherapy for prostate cancer – from the challenges of moving treatments from bench to bedside, to the importance of collaborative team-science, and the role of deep biological correlates in informing future studies.
Beyond her clinical and research achievements, Dr. Dorff reflects on mentorship, work-life balance, and the importance of supporting diversity in academic medicine. She shares how creative pursuits help her recharge and offers advice for aspiring oncologists to pursue their passions and embrace bold leaps at the edge of breakthrough.
Listen and subscribe wherever you get your podcasts.
More posts featuring Sumanta Pal.